What does Connecticut Innovations invest in?
Connecticut Innovations invests most often at Venture and Seed (60% of the rounds on record), in sectors such as Biotech, IT and Artificial Intelligence.

United States · Investor
Last cheque observed Oct 2026; 264 cheques on record.
Deploying nowGovernment
Follow Connecticut Innovations and see its new cheques in your feed.Start following
30 cheques in the last 12 months
Mostly Venture and Seed: 60% of its rounds
Sole investor in 78 rounds, median $650K
8 exits from the portfolio
We are Connecticut's venture capital arm and the leading source of financing and ongoing support for innovative, growing companies.From their own website
Every round we can evidence, newest first264 appearances
22 rounds
23 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 19 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From their own portfolio page (on their website)
Bright FeedsCuracityEnkoFlyteHealth
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it backed that were later bought or listed8 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Connecticut Innovations. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Connecticut Innovations put money into.
Connecticut Innovations invests most often at Venture and Seed (60% of the rounds on record), in sectors such as Biotech, IT and Artificial Intelligence.
264 investments on record, 30 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: Urologic Design (Pre-seed, Oct 2026), Loops (Seed, Oct 2026) and Intus Bio (Grant, Sept 2026).
The median round it joins is $6.0M. It says it writes cheques of $150K to $7.0M.
Rarely, if at all: none of its 264 investments on record names it as the lead.
Most of the companies it backs are in the United States (90%).
Yes: it is actively investing, with 30 investments in the last 12 months.
Most often LaunchCapital (18 rounds together), Advantage Capital (13 rounds together) and National Science Foundation (11 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it